HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.
Checked against the public recordLast updated Mar 24, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- City of Hope Medical Center
- Interventions being studied
- Other: Best Practice; Other: Educational Intervention; Other: Educational Intervention; Procedure: Genomic Profile; Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Are enrolled in City of Hope (COH) Institutional Review Board (IRB) 07047 * Have a diagnosis of lung, breast, colorectal, pancreatic, ovarian or prostate cancer * Having somatic, germline or paired somatic/germline sequencing * Are fluent in English * Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 * Are \>= 18 years old Exclusion Criteria: * Are unable to provide informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- City of Hope Medical CenterDuarte, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 24, 2026. Always confirm current availability with the study team.